| 영문 | iron | 한글 | 철 |
|---|---|---|---|
| 설명 | 금속원소. 기호 Fe. 원자번호 26. 혈색소와 cytochrome, 기타 호흡기 계통의 효소를 구성하는 중요한 원소이다. |
||
| 영문 | iron deficiency anemia | 한글 | 철결핍빈혈 |
|---|---|---|---|
| 설명 | 적혈구의 기능은 산소를 운반하는데 있다. 적혈구 속에 산소와 결합을 하여 산소를 운반하는 혈색소라는 물질이 있다. 철은 이 혈색소의 중요한 부분을 이루는 것으로 철이 없으면 혈색소가 만들어질 수가 없다. 혈색소가 없으면 역시 적혈구도 만들어지지 않으므로 체내에 철이 부족하면 빈혈이 생긴다. 이 철결핍성 빈혈은 빈혈의 원인 중에서 가장 흔한 것이다(약 25%를 차지한다). 철저장량의 저하-결핍, 혈청철농도의 저하, 트란스페린량 상승, 트란스페린포화도의 저하, 혈색소농도 또는 헤마토크리트의 저하, 저색소성대적혈구를 특징으로 하는 빈혈로서, 생체 내에서 철이 장기에 걸쳐 결핍되며 그 때문에 혈색소 생산 감소에 의해 일어난다. 창자에서의 철흡수량 부족, 철의 수요 증대(유아기, 사춘기, 임신), 철소실과잉(출혈)에 의해 일어나며, 특히 사춘기에서 폐경기까지의 여성에게 많다. 증상으로서는 얼굴창백, 피로감, 피부창백, 손톱 변화(스푼 모양) 등을 나타낸다. 구강 영역에서는 혀의 접촉통, 발적, 건조감, 삼킴곤란을 수반하면 플러머-빈슨(Plummer-Vinson)증후군이라고 한다. 혈액 소견은 혈청철은 저하하며, 철결합능력의 상승, 저색소성 작은적혈구성을 나타낸다. |
||
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
|---|---|
| ADF | administrative determination of fault |
| DDS | damaged disc syndrome; dendrodendritic synaptosome; dental distress syndrome; depressed DNA synthesi... |
| determ | determination, determined |
| FAD | familial Alzheimer dementia; familial autonomic dysfunction; fetal activity-acceleration determinati... |
| PSDA | Patient Self Determination Act |
|---|---|
| TSD | Temperature-dependent sex determination |
| DON | determination of Deoxynivalenol |
| DI | Dialyzed iron |
| HID | High Iron Diamine |
| blood pressure determination | Techniques for measuring blood pressure. (12 Dec 1998) |
|---|---|
| blood volume determination | Method for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight. (12 Dec 1998) |
| gastric acidity determination | Gastric analysis for determination of free acid or total acid. (12 Dec 1998) |
| cell determination | The process by which embryonic cells, previously undifferentiated, take on a specific developmental character. Although the mechanism is not fully understood, homeotic proteins coded for by certain gene sequences (the homeobox) appear to trigger the process. Genes for homeotic proteins show remarkable similarity among species. See: morphogenesis, induction, evocator. (05 Mar 2000) |
| comprehensive wetland determination | <ecology> A type of wetland determination that is based on the strongest possible evidence, requiring the collection of quantitative data for all three wetland identification criteria. (05 Jan 1998) |
| sex determination | Determination of the sex of a foetus in utero by identification of foetal chromosomes. (05 Mar 2000) |
| sex determination (analysis) | Validation of the sex of an individual by inspection of the gonads and/or by genetic tests. (12 Dec 1998) |
| sex determination (genetics) | Process in a given organism, by which the sex genotype is fixed. In humans, sex is established at the time of fertilization by the presence or absence of the y chromosome. (12 Dec 1998) |
| determination | <cell biology> The committment of a cell to a particular path of differentiation, even though there may be no morphological features that reveal this determination. Generally irreversible, but in the case of imaginal discs of Drosophila that are maintained by serial passage, transdetermination may occur. (18 Nov 1997) |
| eligibility determination | Criteria to determine eligibility of patients for medical care programs and services. (12 Dec 1998) |
| faecal fat determination | <investigation> A test that measures the amount of fat in the stool and the percentage of dietary fat that is absorbed. This test is used to evaluate potential fat malabsorption syndromes. Stools are collected for 24 hours. Normal values include less than 7 grams of fat per 24 hours, based on a diet of 100 grams of fat per day for 3 days before the test. Decreased fat absorption can be seen in biliary stricture, biliary cancer, celiac sprue, cholelithiasis, chronic pancreatitis, Crohn's disease, cystic fibrosis, acute pancreatitis, pancreatic cancer, radiation enteritis, short bowel syndromes (post surgical) and Whipple's disease. (27 Sep 1997) |
| albuminised iron | Iron albuminate, a compound of iron oxide and albumin; rendered soluble by the presence of sodium citrate; occurs as reddish brown, lustrous granules, odourless or nearly so; used in anaemia. (05 Mar 2000) |
| anaemia, iron deficiency | Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia, whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men. Anaemia characterised by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low haemoglobin concentration or haematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal haemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anaemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation. (12 Dec 1998) |
| brain iron | <radiology> Normal, Infant: NONE, Adult: globus pallidum, substantia nigra, red nucleus, dentate nucleus, Aging: (adult) and putamen, Degenerative disease, Parkinson disease: putamen, SN compacta, Huntington disease: caudate, putamen, Alzheimer disease: cerebral cortex, Hallervorden-Spatz disease, MS: thalamus, putamen, Others, AVM: malformation and rim, Bleed: rim macrophages, Haemorrhagic CVA: gyral / basal ganglia MRI: low T1 and T2 signal (12 Dec 1998) |
| peptonised iron | A compound of iron oxide and peptone, rendered soluble by the presence of sodium citrate; used in the treatment of iron deficiency anaemia. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|